Harmonised relative effectiveness discussions moving ahead in Europe
This article was originally published in Scrip
Executive Summary
Support for a single European relative effectiveness assessment done by the European Medicines Agency (EMA) is gaining momentum with the pharmaceutical industry, said Andrew Witty, president of the European pharmaceutical industry federation EFPIA at its annual meeting in London this week.